The Filing Desk

Delcath Systems vs Pulse Biosciences

Delcath Systems DCTH · Pulse Biosciences PLSE · Health Care Equipment

Delcath Systems reported revenue of $85 million in fiscal 2025, 284.0 times Pulse Biosciences' $0 million in fiscal 2025. Delcath Systems had an operating margin of 0.8%, against -21982.6% at Pulse Biosciences. Free cash flow was $21 million at Delcath Systems and −$54 million at Pulse Biosciences.

Side by side

Delcath SystemsPulse Biosciences
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$85M$0M
Revenue growth129.1%—
Revenue growth a year, last 5 years——
Gross margin86.2%−54.0%
Operating margin0.8%−21,982.6%
Net margin3.2%−20,794.6%
Free cash flow$21M−$54M
Free cash flow margin24.6%−15,553.4%
Return on capital2.8%—
Net debt to EBITDA−101.4x—
Dividends and buybacks$6M$0M
Change in diluted share count40.0%15.4%
Last close$20.55$50.44
P/E at the last close128.4×—
Insider trades, last 12 months——
Piotroski F-score6 of 93 of 8
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Delcath SystemsPulse Biosciences
Operating margin
Percent of revenue
Delcath SystemsPulse Biosciences
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Delcath SystemsPulse Biosciences

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Delcath Systems and Pulse Biosciences pages.